Gynecologic Malignancies, An Issue of PET Clinics, 1st Edition
Author :
Ora Israel
Positron emission tomography (PET) has been approved for the diagnosis and staging of gynecologic malignancies for several years now. This issue reviews the imaging of cervical, uterine, and endometrial cancers. There is also an articles ...view more
Positron emission tomography (PET) has been approved for the diagnosis and staging of gynecologic malignancies for several years now. This issue reviews the imaging of cervical, uterine, and endometrial cancers. There is also an articles on the uses of PET/CT for imaging normal and abnormal anatomy, as well as gynecologic imaging using other modalities. Lastly this issue contains a review of newer radionuclide tracers currently in development.
Positron emission tomography (PET) has been approved for the diagnosis and staging of gynecologic malignancies for several years now. This issue reviews the imaging of cervical, uterine, and endometrial cancers. There is also an articles on the uses of PET/CT for imaging normal and abnormal anatomy, as well as gynecologic imaging using other modalities. Lastly this issue contains a review of newer radionuclide tracers currently in development.
Author Information
By Ora Israel, Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel
https://www.us.elsevierhealth.com/gynecologic-malignancies-an-issue-of-pet-clinics-9781437725933.html6427Gynecologic Malignancies, An Issue of PET Clinicshttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9781437725933.jpg55.2978.99USDInStock/Medicine/Radiology/Clinics/Clinics424388725525504113841826925145120Positron emission tomography (PET) has been approved for the diagnosis and staging of gynecologic malignancies for several years now. This issue reviews the imaging of cervical, uterine, and endometrial cancers. There is also an articles on the uses of PET/CT for imaging normal and abnormal anatomy, as well as gynecologic imaging using other modalities. Lastly this issue contains a review of newer radionuclide tracers currently in development. Positron emission tomography (PET) has been approved for the diagnosis and staging of gynecologic malignancies for several years now. This issue reviews the imaging of cervical, uterine, and endometrial cancers. There is also an articles on the uses of PET/CT for imaging normal and abnormal anatomy, as well as gynecologic imaging using other modalities. Lastly this issue contains a review of newer radionuclide tracers currently in development. 00add-to-cart97814377259332011 and earlierProfessionalBy Ora Israel20101Book178w x 254h (7.00" x 10.00")Saunders0Dec 14, 2010IN STOCK - This may take up to 5 business days to shipBy <STRONG>Ora Israel</STRONG>, Department of Nuclear Medicine, Rambam Medical Center, Haifa, IsraelClinicsClinicsThe Clinics: RadiologyNoNoNoNoPlease SelectPlease SelectPlease Select
